Atlas Trials

Empagliflozin and Atrial Fibrillation Treatment

Clinical trial NCT04583813 · UNKNOWN

Trial details

NCT number
NCT04583813
Sponsor
Miulli General Hospital
Status
UNKNOWN
Phase
Phase 4
Study type
INTERVENTIONAL
Atrial FibrillationHeart FailureObesityDiabetes Mellitus
Start date
2021-09-01
Primary completion
2024-01-01
Enrollment
400

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.